AV
ARCH Venture Fund IX, L.P. disclosed a 7.3% stake in VIR
ARCH Venture Fund IX, L.P. reported owning 7.3% of Vir Biotechnology, Inc. (VIR) (12,508,029 shares) in a Schedule 13D filed Nov 6, 2026.
A 13D means the holder may push for changes at the company.